Publication:
Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate

dc.contributor.authorHalis, Hulya
dc.contributor.authorMemur, Seyma
dc.contributor.authorKorkmaz, Levent
dc.contributor.authorBastug, Osman
dc.contributor.authorGÜNEŞ, TAMER
dc.contributor.authorKurtoglu, Selim
dc.contributor.institutionauthorKORKMAZ, LEVENT
dc.date.accessioned2020-10-29T19:29:43Z
dc.date.available2020-10-29T19:29:43Z
dc.date.issued2014-09-01T00:00:00Z
dc.description.abstractThe activation of the hypothalamic-pituitary-gonadal axis observed during the first month of life is thought to be a significant phase in the maturation of gonads and potentially be important for the development of reproductive functions. The preterm ovarian hyperstimulation syndrome (POHS) was first detected at postconception 36-39 weeks in a preterm female newborn with edema developing in the vulva, the hypogastric site, and the upper leg. The pathophysiology of this postnatal hormonal change is obscure. In this paper we would like to present a case developing POHS and to discuss possible pathophyslogical mechanisms.
dc.identifier.citationHalis H., Memur S., Korkmaz L., Bastug O., GÜNEŞ T., Kurtoglu S., -Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate-, JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.27, ss.997-999, 2014
dc.identifier.doi10.1515/jpem-2013-0452
dc.identifier.scopus84906990956
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25828
dc.identifier.wosWOS:000341429100032
dc.titleOvarian hyperstimulation syndrome treated by medroxyprogesterone acetate
dc.typeArticle
dspace.entity.typePublication
local.avesis.id4edd6d51-90da-47d6-a3a7-bacc9157e3a2
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication4bc5395a-caf3-4abd-991a-f70ab02b40d2
relation.isAuthorOfPublication.latestForDiscovery4bc5395a-caf3-4abd-991a-f70ab02b40d2

Files

Collections